Previous studies have suggested that a drug indicated for treating rheumatoid arthritis may increase the risk for blood clots. In a new study, researchers assessed this risk further.
Expansion of therapeutic possibilities for psoriatic arthritis have highlighted the need to identify residual disease and opportunities to adjust treatment.
Recently, researchers conducted a study to examine whether the presence of rheumatoid arthritis affected the risk of developing chronic obstructive pulmonary disease or asthma, independent of lifestyle...
Current guidelines recommend disease-modifying antirheumatic drugs be adjusted at least every 3 months for patients with rheumatoid arthritis and moderate to high disease activity. In a recent study,...
In a recent study, researchers investigated whether prolonging the dosing interval of adalimumab for patients with RA was associated with changes in disease activity.
In a recent study, researchers aimed to determine whether the amount of weight lost after Roux-en-Y gastric bypass was associated with long-term changes in bone mineral density, and which factors may be...
In a recent study, researchers compared the effectiveness of treatment with romosozumab and alendronate with standard therapy for the reduction of fracture risk.
In a recent study, researchers examined the potential of a novel cartilage degeneration algorithm to separate individuals based upon predicted level of cartilage degeneration.
